Back to dashboard
All PlansCoverageMedium impact

Quantitative Electroencephalography as a Diagnostic Aid for Attention-Deficit/Hyperactivity Disorder, Cognitive Impairment, or Autism Spectrum Disorder

Blue Cross & Blue Shield of Mississippi·Neurology, Psychiatry, Pediatrics +1 more·Medical Policy
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply
—

Summary

This policy establishes coverage criteria for quantitative electroencephalography (qEEG) as a diagnostic aid for ADHD, cognitive impairment, and autism spectrum disorder. The policy appears to define when qEEG testing may be considered for coverage rather than changing existing billing practices.

Action Required

Action needed
Review policy A.3.01.03 to understand coverage criteria for quantitative EEG testing for ADHD, cognitive impairment, and autism spectrum disorder. Billing team should verify current coverage determination process for qEEG services and ensure prior authorization requirements are followed per established protocols.

Related policy hubs